Black Rock Inc. Sesen Bio, Inc. Transaction History

Black Rock Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.49 - $0.61 $775,149 - $964,982	-1,581,938 Reduced 37.53%	2,633,452 $1.61 Million
Q3 2022 Nov 14, 2022	BUY	$0.0 - $0.93 $0 - $117,852	126,723 Added 3.1%	4,215,390 $1.79 Million
Q2 2022 Aug 12, 2022	SELL	$0.38 - $0.89 $3.53 Million - $8.28 Million	-9,299,224 Reduced 69.46%	4,088,667 $3.31 Million
Q1 2022 May 12, 2022	SELL	$0.58 - $0.86 $58,413 - $86,613	-100,713 Reduced 0.75%	13,387,891 $8.07 Million
Q4 2021 Feb 10, 2022	BUY	$0.73 - $1.28 $1.86 Million - $3.27 Million	2,553,282 Added 23.35%	13,488,604 $11 Million
Q3 2021 Nov 09, 2021	BUY	$0.77 - $4.91 $213,682 - $1.36 Million	277,510 Added 2.6%	10,935,322 $8.67 Million
Q2 2021 Aug 11, 2021	BUY	$2.18 - $4.66 $23.2 Million - $49.7 Million	10,657,812 New	10,657,812 $49.2 Million

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.